Army scientists at Walter Reed National Military Medical Center are weeks away from announcing the development of a coronavirus vaccine that will be effective against the Omicron variant and future variants of this SARS virus, Defense One reports.
Known as the SpFN–for Spike Ferritin Nanoparticle–vaccine, the new vaccine has gone through animal testing and finished Stage 1 human testing this month, with both showing positive signs for the effectiveness and safety of the vaccine.
When they began attempts to develop a vaccine, the scientists at Walter Reed aimed at producing a vaccine that would work for any version of the SARS virus stemming from this coronavirus, foregoing trying to prevent individual strains.
